SuperCom - SPCB Stock Forecast, Price & News

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for SuperCom in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" SPCB shares.
View SPCB analyst ratings or view top-rated stocks.

1 Wall Street research analysts have issued 12-month price objectives for SuperCom's stock. Their SPCB share price forecasts range from $10.00 to $10.00. On average, they predict the company's share price to reach $10.00 in the next twelve months. This suggests a possible upside of 287.6% from the stock's current price.
View analysts price targets for SPCB or view top-rated stocks among Wall Street analysts.

SuperCom's stock was trading at $1.78 at the beginning of 2023. Since then, SPCB stock has increased by 44.9% and is now trading at $2.58.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Thursday, March 30th 2023.
View our SPCB earnings forecast.

SuperCom Ltd. (NASDAQ:SPCB) issued its earnings results on Thursday, November, 11th. The industrial products company reported ($0.30) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.70) by $0.40. The industrial products company had revenue of $3.11 million for the quarter, compared to analysts' expectations of $3.10 million. SuperCom had a negative trailing twelve-month return on equity of 103.51% and a negative net margin of 81.57%.

SuperCom's stock reverse split before market open on Monday, November 21st 2022. The 1-10 reverse split was announced on Monday, November 21st 2022. The number of shares owned by shareholders was adjusted after the closing bell on Monday, November 21st 2022. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

4 employees have rated SuperCom Chief Executive Officer Frank C.W. Luk on Glassdoor.com. Frank C.W. Luk has an approval rating of 48% among the company's employees. This puts Frank C.W. Luk in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other SuperCom investors own include Sorrento Therapeutics (SRNE), Matinas BioPharma (MTNB), Bionano Genomics (BNGO), Heat Biologics (HTBX), Zosano Pharma (ZSAN), ADMA Biologics (ADMA), Nokia Oyj (NOK), Novan (NOVN), Aeterna Zentaris (AEZS) and CBL & Associates Properties (CBL).

SuperCom trades on the NASDAQ under the ticker symbol "SPCB."

Shares of SPCB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of SPCB stock can currently be purchased for approximately $2.58.

SuperCom (NASDAQ:SPCB) has a market capitalization of $9.24 million and generates $12.27 million in revenue each year. The industrial products company earns $-10,140,000.00 in net income (profit) each year or ($5.00) on an earnings per share basis.

SuperCom's mailing address is 20 LINCOLN STREET, TEL AVIV L3, 6713412. The official website for the company is www.supercom.com. The industrial products company can be reached via phone at (729) 889-0850, via email at ir@supercom.com, or via fax at 972-9889-0820.